GSK's ADC Drug Gets FDA's Breakthrough Tag for Rare Bone Cancer

Published on 7 Jan 2025 on Zacks · via Yahoo Finance

GSK's Zacks Rank & Stocks to Consider GSK currently carries a Zacks Rank #4 (Sell). Some...

Read the rest of the article

Start tracking your investments with Statfolio

Alnylam reports preliminary fourth-quarter and full-year 2024 product revenues. The company expec...

Zacks · via Yahoo Finance 13 Jan 2025

Shares of Intellia Therapeutics, Inc. NTLA were down in pre-market trading on Jan. 10 after the...

Zacks · via Yahoo Finance 10 Jan 2025

Sanofi's Sarclisa SC formulation shows non-inferiority versus Sarclisa IV infusion in a late-stag...

Zacks · via Yahoo Finance 10 Jan 2025

Vir Biotechnology posts encouraging initial data from phase I studies evaluating VIR-5818 and...

Zacks · via Yahoo Finance 9 Jan 2025

Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its...

Zacks · via Yahoo Finance 9 Jan 2025

s Zacks Rank & Stock to Consider Solid Biosciences currently carries a Zacks Rank #3 (Hold). A...

Zacks · via Yahoo Finance 8 Jan 2025

GSK's Zacks Rank & Stocks to Consider GSK currently carries a Zacks Rank #4 (Sell). Some...

Zacks · via Yahoo Finance 7 Jan 2025

Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the...

Zacks · via Yahoo Finance 27 Dec 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: TechnipFMC plc FTI: This...

Zacks · via Yahoo Finance 24 Dec 2024

Key Insights Significantly high institutional ownership implies Puma Biotechnology's stock price ...

Simply Wall St. · via Yahoo Finance 23 Dec 2024